A new trading day began on Friday, with Regenxbio Inc (NASDAQ: RGNX) stock price up 6.46% from the previous day of trading, before settling in for the closing price of $9.29. RGNX’s price has ranged from $9.11 to $28.80 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 72.63% over the last five years. Meanwhile, its annual earnings per share averaged 24.63%. With a float of $44.51 million, this company’s outstanding shares have now reached $49.42 million.
The firm has a total of 344 workers. Let’s measure their productivity. In terms of profitability, gross margin is 42.66%, operating margin of -277.01%, and the pretax margin is -270.91%.
Regenxbio Inc (RGNX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Regenxbio Inc is 9.95%, while institutional ownership is 89.97%. The most recent insider transaction that took place on Oct 01 ’24, was worth 101,052. In this transaction Director of this company sold 10,000 shares at a rate of $10.11, taking the stock ownership to the 11,286 shares. Before that another transaction happened on Sep 03 ’24, when Company’s Director sold 10,000 for $11.56, making the entire transaction worth $115,588. This insider now owns 11,286 shares in total.
Regenxbio Inc (RGNX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 24.63% per share during the next fiscal year.
Regenxbio Inc (NASDAQ: RGNX) Trading Performance Indicators
Here are Regenxbio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.53. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.49.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.27, a number that is poised to hit -1.12 in the next quarter and is forecasted to reach -0.79 in one year’s time.
Technical Analysis of Regenxbio Inc (RGNX)
Analysing the last 5-days average volume posted by the [Regenxbio Inc, RGNX], we can find that recorded value of 0.43 million was lower than the volume posted last year of 0.6 million. As of the previous 9 days, the stock’s Stochastic %D was 23.48%. Additionally, its Average True Range was 0.62.
During the past 100 days, Regenxbio Inc’s (RGNX) raw stochastic average was set at 11.30%, which indicates a significant decrease from 28.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 49.89% in the past 14 days, which was lower than the 59.19% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.52, while its 200-day Moving Average is $14.94. Now, the first resistance to watch is $10.22. This is followed by the second major resistance level at $10.55. The third major resistance level sits at $11.04. If the price goes on to break the first support level at $9.39, it is likely to go to the next support level at $8.90. Now, if the price goes above the second support level, the third support stands at $8.57.
Regenxbio Inc (NASDAQ: RGNX) Key Stats
With a market capitalization of 488.76 million, the company has a total of 49,256K Shares Outstanding. Currently, annual sales are 90,240 K while annual income is -263,490 K. The company’s previous quarter sales were 22,300 K while its latest quarter income was -52,990 K.
